NASDAQ:BCRX

Biocryst Pharmaceuticals Stock Predictions

etoro logo Buy BCRX
*Your capital is at risk
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BCRX Prediction Chart

BCRX Predictions History

Latest community submissions for BCRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 20, 2026 $6.75 +1.41% $6.67 V 98.74% 2
Jan 20, 2026 Bullish $6.67 V 1
Jan 16, 2026 $7.03 -2.01% $6.66 V 94.50% 1
Jan 16, 2026 $7.26 +1.26% $6.66 X 90.99% 0
Jan 16, 2026 Bullish $6.66 X 0
Jan 12, 2026 $7.40 +0.00% $7.09 V 95.63% 1
Jan 5, 2026 $7.62 +1.61% $7.41 X 97.16% 0
Jan 5, 2026 $7.58 +1.01% $7.41 X 97.77% 0
Jan 5, 2026 Bullish $7.41 X 0
Nov 11, 2025 $7.08 -1.62% $7.23 X 97.97% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOCRYST PHARMACEUTICALS
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE